Dan Bobear

Dan is a recognized biotech/pharma leader and entrepreneur who brings more than 28 years of leadership experience to Mablytics. He has led commercialization efforts for multiple pharmaceutical brands and has extensive experience working on some of the industry’s largest oncology brands. Dan was the founder and president of The Patient Experience Project (PEP), which developed novel methodologies to ensure that patient populations were at the center of research, clinical trial development, and commercialization efforts. Dan successfully scaled PEP by working with numerous industry-leading brands before it was acquired in 2018 by JLL Partners and Water Street Healthcare Partners under the brand name EVERSANA. Before founding PEP, Dan spent 11 years at inVentiv Health in leadership roles, as well as at leading pharmaceutical and biotech companies, including DuPont Merck Pharmaceuticals and Exact Sciences. Dan has also led successful start-up ventures in communications, multimedia, and biotech, and he is experienced in mergers and acquisitions, financing, and other aspects of business development. Dan is active in philanthropy and serves on 3 not-for-profit boards focused on improving the lives of underserved communities. Dan holds an MBA from Canisius College and a B.S. in business administration from Le Moyne College.